Lack of prognostic significance of SPECT abnormalities in non-demented elderly subjects with memory loss

Canadian Journal of Neurological Sciences

Volumn 26, Issue 1, 1999, Pages 23-28

  McKelvey, R ^a,c,d   Bergman, H ^f   Stern, J ^f   Rush, C ^f   Zahirney, G ^a   Chertkow, H ^a,b,e  

^a MCGILL UNIVERSITY   (Canada)

^b CENTRE DE RECHERCHE   (Canada)

^c DALHOUSIE UNIVERSITY   (Canada)

^d Horizon Health Network   (Canada)

^e MCGILL UNIVERSITY   (Canada)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M;

ADULT; AGED; ALZHEIMER DISEASE; AMNESIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMENTIA; FEMALE; FOLLOW UP; HUMAN; MALE; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; PROGNOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; AGED, 80 AND OVER; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MEMORY DISORDERS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M EXAMETAZIME; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0032986156     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Neary D, Snowdon JS, Shields RA, et al. Single photon emission tomography using 99m Tc-HMPAO in the investigation of dementia. J Neurol Neurosurg and Psychiatry 1987; 50: 1101-1109.
2. Reed BR, Jagust WJ, Scab JP, Ober BA. Memory and regional cerebral blood flow in mildly symptomatic Alzheimer's disease. Neurology 1989; 39: 1537-1539.
3. Johnson KA, Holman BL, Rosen TJ, et al. Iofetamene I-123 single photon emission computed tomography is accurate in the diagnosis of Alzheimer's disease. Arch Int Med 1990; 150: 752-756.
4. Ishii K, Mori E, Kitagaki H, et al. The clinical utility of visual evaluation of scintigraphic perfusion patterns for Alzheimer's disease using I-123 IMP SPECT. Clin Nuclear Med 1996; 21(2): 106-110.
5. Stoppe G, Staedt J, Kogler A, et al. 99mTc-HMPAO-SPECT in the diagnosis of senile dementia of Alzheimer's type - a study under clinical routine conditions. J Neural Trans 1995; 99(1-3): 195-211.
6. Read SL, Miller BL, Mena I, et al. SPECT in dementia: clinical and pathological correlation. J Am Geriatr Soc 1995; 43(11): 1243-1247.
7. Villa G, Cappa A, Tavolozza M, et al. Neuropsychological tests and [99mTc] - HM PAO SPECT in the diagnosis of Alzheimer's dementia. J Neurol 1995; 242(6): 359-366.
8. Waldemar G. Functional brain imaging with SPECT in normal aging and dementia. Methodological, pathophysiological, and diagnostic aspects. [Review]. Cerebrovasc Brain Metab Rev 1995; 7(2): 89-130.
9. Wolfe N, Reed BR, Eberling JL, Jagust WJ. Temporal lobe perfusion on single photon emission computed tomography predicts the rate of cognitive decline in Alzheimer's disease. Arch Neurol 1995; 52: 257-262.
10. Golan H, Kremer J, Freedman M, Ichise M. Usefulness of follow-up regional cerebral blood flow measurements by single-photon emission computed tomography in the differential diagnosis of dementia. J Neuroimaging 1996; 6(1): 23-28.
11. Bergman H, Chertkow H, Wolfson C, et al. HM-PAO (CERETEC) SPECT brain scanning in the diagnosis of Alzheimer's disease. J Am Geriatr Soc 1997; 45: 15-20.
12. Claus JJ, Van Horskamp F, Breteler MMB, et al. The diagnostic value of SPECT with Tc99m HMPAO in Alzheimer's disease: a population based study. Neurology 1994; 44: 454-461.
13. Masterman D, Mendez M, Fairbanks L, Cummings J. Sensitivity, specificity, and positive predictive value of HM-PAO SPECT in discriminating Alzheimer's Disease from other dementias. J Geriatr Psych Neurol, 1997; 10, 15-21.
14. Weinstein HC, Hoan J, Van Royer EO, et al. SPECT in the diagnosis of Alzheimer's disease and multi-infarct dementia. Clin Neurol Neurosurgery 1991; 93: 39-43.
15. Mattman A, Feldman H, Forster B, et al. Regional HmPAO SPECT and CT measurements in the diagnosis of Alzheimer's Disease. Can J Neurol Sci 1997; 24(1), 22-28.
16. Jagust WJ. Functional imaging patterns in Alzheimer's disease. Relationships to neurobiology. [Review]. Ann NY Acad Sci 1996; 777: 30-36.
17. Celsis P, Agniel A, Cardebat D, et al. Age related cognitive decline: a clinical entity? A longitudinal study of cerebral blood flow and memory performance. J Neurol Neurosurg Psychiatry 1997; 62(6): 601-608.
18. Rubin EH, Morris JC, Grant A, Vendegna T. Very mild senile dementia of the Alzheimer type: I. Clinical assessment. Arch Neurol 1989; 46: 379-382.
19. Tuokko H, Vernon-Wilkinson R, Weir J, Beattie BL. Cued recall and early identification of dementia. J Clin Exp Neuropsychol 1991; 13(6): 871-879.
20. Levy R (Chairperson). Aging associated cognitive cecline: working party of the International Psychogeriatric Association in collaboration with the World Health Association. Internal Psychogeriatr 1994; 6(1): 63-68.
21. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984; 34: 939-944.
22. Berg L, Hughes CP, Coben LA et al. Mild senile dementia of the Alzheimer type: research diagnostic criteria, recruitment, and a description of a study population. J Neurol Neurosurg Psychiatry 1982; 45: 962-968.
23. O'Brien JT, Beats B, Hill K, et al. Do subjective memory complaints precede dementia? A three-year follow-up of patients with supposed "benign senescent forgetfulness". Internat J Geriatr Psychiatry 1992; 7: 481-486.
24. Grober E, Buschke H, Crystal H, et al. Screening for dementia by memory testing. Neurology 1988; 38: 900-903.
25. Grober E, Sliwinsky M. Development of a model for estimating premorbid verbal intelligence in the elderly. J Clin Exp Neuropsychol 1991; 13(6): 93-949.
26. Morris JC, McKeel DW, Storandt M, et al. Very mild Alzheimer's disease: informant-based clinical, psychometric, and pathologic distinction from normal aging. Neurology 1991; 41: 469-478.
27. Flicker C, Ferris SH, Reisberg B. Mild cognitive impairment in the elderly: predictors of dementia. Neurology. 1991; 41: 1006-1009.
28. Weschler D. Weschler Memory Scale - Revised. New York, NY: Psychological Corporation, 1987.
29. Knopman D, Ryberg S. A verbal memory test with high predictive accuracy for dementia of the Alzheimer's type. Arch Neurol 1989; 46: 141-145.
30. Folstein M, Folstein S, McHugh PR. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. Psychiatr Res 1975; 12: 189-198.
31. Hachinski VC, Iliff LD, Zilhka E, et al. Cerebral blood flow in dementia. Arch Neurol 1975; 32: 632-637.
32. Mack WJ, Freed DM, Williams BW, Henderson VW. Boston Naming Test: shortened versions for use in Alzheimer's disease. J Gerontol Psychol Sci 1992; 47, No.3: 154-158.
33. Thurstone LL, Thurstone TG. Primary mental abilities. Psychometric Monographs, No. 1. Chicago, IL: University of Chicago Press, 1938.
34. Weschler D. Manual for the WAIS-R. New York, NY: Psychological Corporation, 1981.
35. Tuokko H, Hadjistavropoulos T, Miller JA, Beattie BL. The clock test: a sensitive measure to differentiate normal elderly from those with Alzheimer disease. J Am Geriatr Soc 1992; 40: 579-584.
36. Holman BL, Johnson KA, Gerada B, et al. The scintigraphic appearance of Alzheimer's disease: a prospective study using technetium 99m-HMPAO SPECT. J Nuclear Med 1992; 33: 181-185.
37. Joachim CL, Morris J, Selkoe DJ. Clinically diagnosed Alzheimer's disease: autopsy results in 150 cases. Ann Neurol 1988; 24: 50-56.
38. Katzman R, Lasker B, Benstin N. Advances in the diagnosis and consequences of misdiagnosis of disorders causing dementia. In: Terry RD, ed. Aging and the Brain, vol. 32. New York: Raven Press, 1988; 17-62.
39. Berg L, Morris JC. Diagnosis. In: Terry RD, Katzman R, Bick KL, eds. Alzheimer Disease. New York: Raven Press, 1994; 9-25.
40. Chertkow H, Bub D. Semantic memory loss in dementia of Alzheimer's type: What do various measures measure? Brain 1990; 113: 397-417.